Pharma News

A National Institutes of Health study found that chronic treatment with mirabegron, a drug approved to treat overactive bladder, activated brown fat in a small group of healthy women and had several other beneficial metabolic effects. Brown fat, or brown adipose tissue, is a form of fat that burns calories to generate heat. The research, led by Aaron Cypess, M.D., Ph.D., at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was published on Jan. 21 in the Journal of Clinical Investigation.

Women who breastfed their infants exclusively for seven to 12 months may have a significantly lower risk of early menopause than their peers who breastfed their infants for less than a month, according to an analysis funded by the National Institutes of Health. The study also suggests that pregnancy can reduce the risk of early menopause.

Amazon pharmacy is expanding its working outside US and potentially in India, Canada, U.K. and Australia. Recently, Amazon has filed to trademark “Amazon Pharmacy” in Canada, the U.K. and Australia, signaling a potential move into selling prescription drugs outside of the U.S. reported by CNBC.

As per WHO update (as of 11th January, 2020) in all, 41 cases of Novel Coronavirus have been reported so far from China [including one death (further update is awaited)]. As per WHO risk assessment, the risk for global spread, as of now, remains low.

Tobacco smokers are at significantly higher risk than non-smokers for post-surgical complications including impaired heart and lung functions, infections and delayed or impaired wound healing.

EMA’s safety committee (PRAC) recommended that patients stop using Picato (ingenol mebutate), a gel for treating the skin condition actinic keratosis, while it continues its review of the medicine’s safety.

Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant infections, says the World Health Organization (WHO).

A French-Swiss consortium is conducting exploratory research to develop a“smart  bra”  for  detecting  breast  cancer.  It  wants  to  leverage  technological  progress  to  offer  a  more  accessible  diagnostic  method  than  mammography.  This  initiative  –  that  involves  five  partners  –  is supported in France by the FEDER (European fund for regional development) and in Switzerland by the Confederation  and  the  canton  of  Neuchâtel  within  the  framework  of  the  European  program  for  regional cooperation Interreg France-Switzerland.

Strides Pharma Science Limited (Strides)  announced that its step down subsidiary, Strides Pharma Inc. (SPI), has received an Establishment Inspection Report (EIR) from the USFDA for its facility in Riviera Beach, Florida, US. The EIR was issued as an outcome of the USFDA’s inspection of the facility in December 2019. This facility is one of the very few manufacturing facilities in the US with a soft gel capsule(SGC) manufacturing suite for formulations with containment needs.